Navellier & Associates Inc. grew its position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 4.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 14,552 shares of the biotechnology company’s stock after buying an additional 674 shares during the period. Axon Enterprise makes up 1.0% of Navellier & Associates Inc.’s portfolio, making the stock its 20th largest position. Navellier & Associates Inc.’s holdings in Axon Enterprise were worth $8,649,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in AXON. Prestige Wealth Management Group LLC grew its stake in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the period. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise in the 4th quarter valued at approximately $40,000. Brooklyn Investment Group acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at approximately $41,000. Y.D. More Investments Ltd bought a new stake in Axon Enterprise during the 4th quarter worth approximately $45,000. Finally, Planning Capital Management Corp raised its holdings in Axon Enterprise by 83.3% during the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the period. Institutional investors own 79.08% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have recently weighed in on AXON. TD Cowen initiated coverage on shares of Axon Enterprise in a report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Needham & Company LLC upped their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research note on Friday, November 8th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target on the stock. in a research note on Thursday. Robert W. Baird upped their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Finally, JMP Securities lifted their target price on Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 4th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $561.31.
Axon Enterprise Stock Performance
NASDAQ AXON opened at $513.22 on Friday. The firm has a market capitalization of $39.13 billion, a P/E ratio of 132.62, a price-to-earnings-growth ratio of 5.43 and a beta of 1.05. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The firm’s fifty day moving average price is $619.94 and its two-hundred day moving average price is $517.11. Axon Enterprise, Inc. has a 1 year low of $265.32 and a 1 year high of $715.99.
Insider Transactions at Axon Enterprise
In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Joshua Isner sold 1,291 shares of the company’s stock in a transaction on Tuesday, December 17th. The shares were sold at an average price of $642.43, for a total transaction of $829,377.13. Following the completion of the transaction, the president now owns 181,892 shares in the company, valued at approximately $116,852,877.56. This represents a 0.70 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,711 shares of company stock worth $5,631,561 in the last ninety days. Insiders own 6.10% of the company’s stock.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Consumer Staples Stocks, Explained
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- What is the FTSE 100 index?
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.